iSpecimen Inc.
ISPC
$5.62
$0.397.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 51.80K | 106.60K | 713.10K | 1.06M | 1.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.80K | 106.60K | 713.10K | 1.06M | 1.48M |
| Cost of Revenue | 598.80K | 204.60K | 444.20K | 657.30K | 1.32M |
| Gross Profit | -547.10K | -98.00K | 269.00K | 400.20K | 151.40K |
| SG&A Expenses | 1.61M | 2.18M | 1.55M | 1.49M | 5.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.74M | 2.94M | 2.53M | 2.70M | 7.32M |
| Operating Income | -2.69M | -2.83M | -1.82M | -1.64M | -5.84M |
| Income Before Tax | -5.00M | -2.78M | -1.05M | -1.66M | -6.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.00M | -2.78M | -1.05M | -1.66M | -6.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.00M | -2.78M | -1.05M | -1.66M | -6.05M |
| EBIT | -2.69M | -2.83M | -1.82M | -1.64M | -5.84M |
| EBITDA | -2.62M | -2.77M | -1.76M | -1.57M | -5.78M |
| EPS Basic | -25.94 | -19.05 | -16.78 | -28.55 | -213.80 |
| Normalized Basic EPS | -16.21 | -11.90 | -10.49 | -17.85 | -133.62 |
| EPS Diluted | -25.94 | -19.05 | -16.78 | -28.55 | -213.80 |
| Normalized Diluted EPS | -16.21 | -11.90 | -10.49 | -17.85 | -133.62 |
| Average Basic Shares Outstanding | 192.80K | 146.00K | 62.40K | 58.10K | 28.30K |
| Average Diluted Shares Outstanding | 192.80K | 146.00K | 62.40K | 58.10K | 28.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |